Scientific Advisory Board
Dr. Eric Verdin
Dr. Verdin is the President and CEO of the Buck Institute for Research on Aging. His laboratory studies the relationship between ageing and the immune system. A native of Belgium, Dr. Verdin completed his clinical and research training at Harvard Medical School. He has held senior appointments at several international medical schools, and is also a professor of medicine at University of California, San Francisco. Dr. Verdin has extensive experience working with biotech companies, including Novartis, Roche, Pfizer, and now Hooke.